CME Group (CME) FY2013 results: revenue $2.9 billion, up 0.7% on the year
CME Group Inc. (CME) reported revenue of $2.9 billion for fiscal 2013, the year ended 31 December 2013, up 0.7% on the year before. Net income was $977 million, up 9.0%, and diluted earnings per share $2.92. The figures are the company's own, from the 10-K it filed with the SEC on 3 March 2014.
Revenue
$2.9 billion
+0.7% on the year
FY2007FY2013
Operating margin
55.8%
58.1% a year earlier
FY2007FY2013
Net income
$977 million
+9.0% on the year
FY2007FY2013
Diluted EPS
$2.92
+8.1% on the year
FY2007FY2013
this yearthe year beforeHover a bar for its figure.
The year in brief
Income statement (profit and loss)
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Revenue
2,936
2,915
3,281
+0.7%
Operating income
1,637
1,692
2,021
-3.3%
Operating margin
55.8%
58.1%
61.6%
Pre-tax income
1,601
1,693
1,936
-5.5%
Income tax
623
787
122
-20.8%
Effective tax rate
38.9%
46.5%
6.3%
Net income
977
896
1,812
+9.0%
Net margin
33.3%
30.8%
55.2%
Diluted EPS
$2.92
$2.70
$5.43
+8.1%
$ million except per share. Read moreFree cash flow is operating cash flow less capital expenditure; the effective tax rate is income tax over pre-tax income; margins are the line over revenue. Gross profit is revenue less cost of revenue, and operating income is revenue less the company's own total costs, where the statement does not print those lines. Those four are arithmetic on the filed numbers; everything else is as filed. Money is in $ million as the company files it, or in $ billion by the switch above the tables; per share figures and share counts are as they are.
Cash flow
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Operating cash flow
1,280
1,220
1,346
+5.0%
Capital expenditure
126
142
172
-11.4%
Free cash flow
1,155
1,078
1,174
+7.1%
Free cash flow margin
39.3%
37.0%
35.8%
Cash from investing
190
-209
-154
Cash from financing
-606
-448
-1,006
Depreciation and amortisation
135
137
128
-1.3%
Share-based compensation
54.4
61.4
51.3
-11.4%
Buybacks
0.0
0.0
220
Dividends paid
599
1,224
373
-51.1%
Dividend per share
$4.40
$3.70
$0.22
+18.9%
Diluted shares, weighted
334m
332m
334m
+0.6%
Balance sheet
$ million
FY2013
FY2012
FY2011
On the year
Last 8 years
Shareholders' equity
21,155
21,419
21,552
-1.2%
Non-controlling interest
5.7
5.8
0.0
-1.7%
Redeemable equity
0.0
80.8
70.3
Short-term borrowings
n/a
n/a
0.0
Debt
2,857
2,856
2,107
+0.0%
Other liabilities
30,260
14,501
17,030
+108.7%
Total liabilities and equity
54,278
38,863
40,759
+39.7%
Fixed assets
513
724
822
-29.1%
Goodwill
7,569
7,567
7,984
+0.0%
Intangible assets
2,741
2,854
3,313
-3.9%
Investments
68.4
56.6
47.6
+20.8%
Trading assets
49.6
38.7
31.8
+28.2%
Cash and equivalents
2,470
1,605
1,042
+53.9%
Receivables
303
268
289
+13.2%
Other assets
40,564
25,751
27,229
+57.5%
Total assets
54,278
38,863
40,759
+39.7%
10-K for the year ended 31 December 2013, filed 3 March 2014: the filing.